PharmaCenter Bonn, Pharmaceutical Sciences Bonn (PSB), University of Bonn, Pharmaceutical Institute, An der Immenburg 4, 53121 Bonn, Germany.
Beilstein J Org Chem. 2012;8:1584-93. doi: 10.3762/bjoc.8.181. Epub 2012 Sep 20.
Dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione derivatives were prepared by successive N3- and N1-alkylation of hydantoins, followed by regioselective thionation and subsequent cyclization under mild conditions. In a final alkylation step a further substituent may be introduced. The synthetic strategy allows broad structural variation of this new drug-like heterobicyclic scaffold. In addition to extensive NMR and MS analyses, the structure of one derivative was confirmed by X-ray crystallography.
二氢咪唑并[5,1-c][1,2,4]三嗪-3,6(2H,4H)-二酮衍生物是通过连续的 N3-和 N1-烷化海因,然后在温和条件下进行区域选择性硫代和随后的环化反应制备的。在最后一步烷基化反应中,可以引入进一步的取代基。该合成策略允许广泛改变这种新型类药杂双环支架的结构。除了广泛的 NMR 和 MS 分析外,还通过 X 射线晶体学确定了一种衍生物的结构。